Viewing Study NCT05165394

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:39 AM
Ignite Modification Date: 2026-03-11 @ 9:26 PM
Study NCT ID: NCT05165394
Status: COMPLETED
Last Update Posted: 2024-07-31
First Post: 2021-12-07
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Study to Evaluate the Efficacy and Safety of Once-Weekly Oral NBI-1065846 in the Treatment of Anhedonia in MDD
Sponsor: Neurocrine Biosciences
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Anhedonia View
None Major Depressive Disorder View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Anhedonia View
None Major Depressive Disorder View
None MDD View
None NBI-1065846 View
None TERPSIS View
None Neurocrine View
None Antidepressant View
None Depression View
None TAK-041 View